COMPANY

Persista Bio

HQ: City Of Lewes, DE source · persistabio.com ↗

Keywords: cell therapy

Location: City Of Lewes, DE · source · Apr 29, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.01M (SBIR Phase II 5R44DK142496-02, continuation, notice Jul 31, 2026). NIH RePORTER 5R44DK142496-02 (Jul 31, 2026)
Evidence (1 event)
- Jul 31, 2026 · NIH RePORTER 5R44DK142496-02
  Organization: PERSISTA BIO INC; City/State: ITHACA, NY; Project number: 5R44DK142496-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-31; FY total cost (award amount): 1006033; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Advanced Pre-Clinical Development of O2LineTM System for Type 1 Diabetes Cell Therapy; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals